title: Mogamulizumab benefits seen in cutaneous T-cell lymphoma.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Tanday
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D054398:Receptors, CCR4 / Q000235:genetics
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C515354:CCR4 protein, human; D054398:Receptors, CCR4; C549035:mogamulizumab